Announcements Trials

Browse Landscape

Status

Withdrawn 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Mouth Neoplasms 1 Mouth Diseases 1 Lung Neoplasms 1 Lichen Planus, Oral 1 Leukoplakia, Oral 1 Keratosis, Actinic 1 Graft vs Host Disease 1 Glioma 1 Actinic cheilitis 1

Interventions

pembrolizumab 49 Carboplatin 44 Magnetic Resonance Spectroscopy 40 Specimen Handling 39 Pemetrexed 35 Cisplatin 26 Blood Specimen Collection 25 durvalumab 17 Paclitaxel 17 osimertinib 15 Radiosurgery 15 Bevacizumab 15 Radiotherapy 14 Nivolumab 14 Gemcitabine 14 atezolizumab 13 Biopsy 13 Drug Therapy 12 Docetaxel 11 130-nm albumin-bound paclitaxel 11 Immunoglobulin G 10 X-Rays 9 Taxes 9 Standard of Care 9 Practice Guidelines as Topic 9 Educational Status 9 Disulfides 9 tislelizumab 8 Etoposide 8 Cetuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Tomography, Optical Coherence × Clear all

NCT06419114 2024-05-20

OCTGTBIPPL

Sichuan Provincial People's Hospital

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡